Semaglutide starting at $175 and Tirzepatide $275!
.png)
One single price every month, with everything included. No membership fees. No sign up fees. Join today and start your journey!
Includes:
.png)
Includes:
.png)
(*)Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality. Visit our Medication Safety Information.
Important Information About Compounded Tirzepatide
At E-TeleHub, compounded Tirzepatide is a patient-specific medication prescribed by a licensed healthcare provider following a thorough medical evaluation. This medication is prepared by a 503(a) Compounding Pharmacy or a 503(b) FDA-registered Outsourcing Facility in accordance with applicable regulations.
Please note that compounded medications are not FDA-approved and do not undergo the same pre-market review process as commercially available drugs. As a result, their efficacy, safety, and side-effect profiles may differ from FDA-approved versions. Data from clinical trials involving FDA-approved medications should not be assumed to apply to compounded alternatives. E-TeleHub partners only with licensed U.S. compounding pharmacies that meet stringent quality and compliance standards to ensure patients receive safe, custom-formulated care.
Important Information About Compounded Semaglutide
At E-TeleHub, compounded Semaglutide is a custom-prescribed medication formulated based on an individualized medical assessment conducted by a licensed healthcare provider. It is prepared by a 503(a) Compounding Pharmacy or a 503(b) FDA-registered Outsourcing Facility, in compliance with applicable compounding regulations.
Please be aware that compounded Semaglutide is not FDA-approved and has not undergone the FDA’s pre-market review process. Therefore, its efficacy, safety, and side-effect profile may differ from that of the FDA-approved Semaglutide products. Data from clinical trials on FDA-approved Semaglutide should not be used to evaluate compounded versions.
Please contact us if you don't see the answer you're looking for
Get StartedE-Tele offers medical weight loss program that's physician lead to help you achieve your weight loss goals
We are here to serve you on your schedule. We deliver Simple, convenient and private solutions to fit your needs. Follow the links to fill out an E-Consult form on your schedule, not ours.
We do not require insurance, our weight loss programs are affordable to make it convenient for you to pay
Semaglutide is a GLP-1 receptor agonist used for managing type 2 diabetes and for weight management. It mimics a hormone that helps regulate blood sugar and appetite.
Tirzepatide is a newer injectable medication that works similarly to semaglutide but with a broader effect. It activates both the GLP-1 and GIP (Gastric Inhibitory Polypeptide) receptors to help control blood sugar and promote weight loss.
Both medications help lower blood sugar by increasing insulin secretion when blood sugar levels are elevated. They also slow gastric emptying, leading to reduced appetite and potential weight loss.
Semaglutide is approved for managing type 2 diabetes and for chronic weight management in adults with obesity or overweight (when combined with diet and exercise).
Tirzepatide is approved for managing type 2 diabetes and is also approved for chronic weight management in adults with obesity or overweight (similar to Semaglutide)..
Yes, it is approved for weight loss in individuals with obesity or overweight with related health issues
Nausea, vomiting, diarrhea, and constipation are common side effects.
It’s injected subcutaneously (under the skin) once a week.
If you miss a dose, take it as soon as you remember, unless the next dose is due within 2 days.
Yes, studies suggest it is safe for long-term use, but ongoing monitoring is recommended.
If you miss a dose, take it as soon as you remember, unless the next dose is due within 2 days.
Moderate alcohol consumption is usually fine, but excessive drinking should be avoided
It typically does not cause low blood sugar unless used with other diabetes medications that lower glucose.
Yes, but consult your healthcare provider, especially if you're taking other diabetes medications or blood pressure medications. .
People with a history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should avoid it.
Yes, it improves insulin sensitivity, which may help with insulin resistance.
Blood sugar improvements may be seen within the first few weeks, but weight loss effects may take longer.
Keep it in the refrigerator until use
Blood sugar improvements may be seen within the first few weeks, but weight loss effects may take longer.
No, Semaglutide is not addictive.
Yes, it is approved for weight loss in people with obesity or related conditions.
Side effects include nausea, diarrhea, vomiting, and decreased appetite
E-Pharm Hub, LLC (DBA E-TeleHub and E-Tele) partners with independent licensed physician networks, including MDI Medical Group, P.C., to deliver medical services through the E-Pharm Hub, LLC (DBA E-TeleHub and E-Tele) infrastructure. E-Pharm Hub, LLC (DBA E-TeleHub and E-Tele) does not directly provide medical or pharmacy services. Payment does not guarantee a prescription will be written or dispensed, and you are only charged if a prescription is issued. Medical services are rendered by independent providers. Actual medication form and appearance may differ from what is shown.
Information on this website is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. If you have health-related questions or concerns, please consult your doctor. This website is an advertisement for services, not for any specific medication. Disclaimer: Saxenda®, Victoza®, Wegovy®, and Ozempic® are trademarks of Novo Nordisk™, while Mounjaro™ is a product of Eli Lilly and Company™. E-Tele is not associated with or endorsed by these companies or their products. We do not supply these medications. Individuals interested in these products should consult with their licensed healthcare provider or pharmacist. Compounded semaglutide is offered in response to the ongoing FDA Drug Shortage. For up to date information on drug shortage statuses,
please visit: https://www.accessdata.fda.gov/scripts/drugshortages/
